thyroxine has been researched along with Tachycardia, Ventricular in 7 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 7.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Cases of hypothyroidism and hyperthyroidism associated with amiodarone therapy are described, and the mechanisms, clinical appearance, and management of amiodarone-induced thyroid dysfunction are discussed." | 4.78 | Amiodarone-induced thyroid dysfunction. ( Jaffe, CA; Khanderia, U; Theisen, V, 1993) |
| "Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 3.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Hyperthyroidism is a reason for immediately suspending treatment for 90% of the cardiologists, only 5% would continue and 16% would prescribe antithyroid drugs." | 1.30 | [Amiodarone and thyroid function: clinical implications]. ( Binz, K; Burger, A; Vallotton, MB, 1998) |
| "Patients with ventricular tachycardia demonstrated significantly lower serum values of FT3 and FT3/FT4, and significantly higher values of rT3." | 1.29 | [Serum thyroid hormone levels correlate with cardiac function and ventricular tachyarrhythmia in patients with chronic heart failure]. ( Inoue, T; Maeda, T; Niwa, H; Saikawa, T; Shimoyama, N, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, P | 1 |
| Dietrich, JW | 1 |
| Lin, T | 1 |
| Bejinariu, A | 1 |
| Binnebößel, S | 1 |
| Bergen, F | 1 |
| Schmidt, J | 1 |
| Müller, SK | 1 |
| Chatzitomaris, A | 1 |
| Kurt, M | 1 |
| Gerguri, S | 1 |
| Clasen, L | 1 |
| Klein, HH | 1 |
| Kelm, M | 1 |
| Makimoto, H | 1 |
| Nevzorov, R | 1 |
| Shleyfer, E | 1 |
| Gourevitch, A | 1 |
| Jotkowitz, A | 1 |
| Porath, A | 1 |
| Barski, L | 1 |
| Hermida, JS | 1 |
| Jarry, G | 1 |
| Tcheng, E | 1 |
| Moullart, V | 1 |
| Arlot, S | 1 |
| Rey, JL | 1 |
| Schvartz, C | 1 |
| Shimoyama, N | 1 |
| Maeda, T | 1 |
| Inoue, T | 1 |
| Niwa, H | 1 |
| Saikawa, T | 1 |
| Khanderia, U | 1 |
| Jaffe, CA | 1 |
| Theisen, V | 1 |
| Iervasi, G | 1 |
| Clerico, A | 1 |
| Berti, S | 1 |
| Pilo, A | 1 |
| Biagini, A | 1 |
| Bianchi, R | 1 |
| Donato, L | 1 |
| Binz, K | 1 |
| Burger, A | 1 |
| Vallotton, MB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation[NCT04392258] | 200 participants (Anticipated) | Observational | 2021-05-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for thyroxine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Male; Tachycardia, Ventricular; Th | 1993 |
1 trial available for thyroxine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Normalization of peripheral thyroid hormone metabolism induced by successful chronic amiodarone treatment in patients with ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Cardiac Complexes | 1996 |
5 other studies available for thyroxine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease.
Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Cohort Studies; Defibrillators, Implantable; Ele | 2020 |
Campylobacter-associated myopericarditis with ventricular arrhythmia in a young hypothyroid patient.
Topics: Abdominal Pain; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Atenolol; Campylobacter Infect | 2010 |
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hea | 2004 |
[Serum thyroid hormone levels correlate with cardiac function and ventricular tachyarrhythmia in patients with chronic heart failure].
Topics: Echocardiography; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Tachycardia, | 1993 |
[Amiodarone and thyroid function: clinical implications].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Male; Myocardial Infarction; Ta | 1998 |